Skip to main content
. 2017 Dec 28;18:622. doi: 10.1186/s13063-017-2344-2

Table 2.

Secondary outcomes

Outcome Time point
Time to first respiratory exacerbation
Time to death
Number of acute exacerbations By 12 months
Number of hospitalisations By 12 months
Number of mild, moderate and severe adverse events By 12 months
Mean weight-for-age z-score adjusted for baseline By 12 months
Incidence of infectious episodes (Salmonella typhi, malaria, gastroenteritis) By 12 months
Durability of effect (FEV1 z-score) 18 months

FEV 1 Forced expiratory volume in 1 second